Advisor Group Holdings, Inc. Pacira Bio Sciences, Inc. Transaction History
Advisor Group Holdings, Inc.
- $39.8 Billion
- Q4 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 793 shares of PCRX stock, worth $21,038. This represents 0.0% of its overall portfolio holdings.
Number of Shares
793
Previous 740
7.16%
Holding current value
$21,038
Previous $11,000
27.27%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding PCRX
# of Institutions
253Shares Held
46.5MCall Options Held
436KPut Options Held
369K-
Black Rock Inc. New York, NY8.01MShares$212 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$140 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$86.6 Million0.15% of portfolio
-
State Street Corp Boston, MA2.01MShares$53.4 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.99MShares$52.9 Million0.06% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.22B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...